ALCEMISTE

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: ALCEMISTE
Generic name: LIDOCAINE HCL
Manufacturer: Price Team Ventures, LLC
Product type: HUMAN OTC DRUG
SPL set ID: 4383faaa-49cf-47b7-83a6-c2a94b6ff9b5
SPL ID: 3e130768-8805-93a4-e063-6294a90a5bfd
Version: 1
Effective date: 2025-09-05
Source export date: 2026-11-06
Source partition: 12
Source file: https://download.open.fda.gov/drug/label/drug-label-0012-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-11-06/39f3c0903357a80632a5484c9d6a804272f4b297080aa9c5a01a84db133f7a03/drug-label-0012-of-0014.json.zip
Source manifest SHA-256: 4a7570ba105b5a039a8e1c94a85e7f085b9047a8882a35a96bf1e4516c5ffc97
Import run: 20261108T063105Z
Imported at: 2026-11-08 08:01:09

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M017	openfda.application_number
brand name		ALCEMISTE	openfda.brand_name
generic name		LIDOCAINE HCL	openfda.generic_name
manufacturer name		Price Team Ventures, LLC	openfda.manufacturer_name
ndc	package	87087-001-01	openfda.package_ndc
ndc	product	87087-001	openfda.product_ndc
ndc11	package	87087000101	derived:openfda.package_ndc
rxcui		1010895	openfda.rxcui
spl id		3e130768-8805-93a4-e063-6294a90a5bfd	id
spl set id		4383faaa-49cf-47b7-83a6-c2a94b6ff9b5	set_id
unii		V13007Z41A	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings 1. For external use only 2. Avoid contact with the eyes 3. Stop use and consult a doctor if : Condition worsens or symptoms persist for more than 7 days Symptoms clear up and occur again within a few days Avoid excessive use, especially on raw or blistered skin. Do not exceed the recommended daily dosage unless advised by a doctor. Do not use on wounds or damaged skin. Keep out of reach of children . If swallowed, seek immediate medical attention or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.